Survey-Based Assessment of Water, Sanitation, and Animal-Associated Risk Factors for Moderate-to-Severe Diarrhea in the Vaccine Impact on Diarrhea in Africa (VIDA) Study: The Gambia, Mali, and Kenya, 2015-2018.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
19 04 2023
Historique:
medline: 21 4 2023
pubmed: 19 4 2023
entrez: 19 04 2023
Statut: ppublish

Résumé

Pediatric exposures to unsafe sources of water, unsafely managed sanitation, and animals are prevalent in low- and middle-income countries. In the Vaccine Impact on Diarrhea in Africa case-control study, we examined associations between these risk factors and moderate-to-severe diarrhea (MSD) in children <5 years old in The Gambia, Kenya, and Mali. We enrolled children <5 years old seeking care for MSD at health centers; age-, sex-, and community-matched controls were enrolled at home. Conditional logistic regression models, adjusted for a priori confounders, were used to evaluate associations between MSD and survey-based assessments of water, sanitation, and animals living in the compound. From 2015 to 2018, 4840 cases and 6213 controls were enrolled. In pan-site analyses, children with drinking water sources below "safely managed" (onsite, continuously accessible sources of good water quality) had 1.5-2.0-fold higher odds of MSD (95% confidence intervals [CIs] ranging from 1.0 to 2.5), driven by rural site results (The Gambia and Kenya). In the urban site (Mali), children whose drinking water source was less available (several hours/day vs all the time) had higher odds of MSD (matched odds ratio [mOR]: 1.4, 95% CI: 1.1, 1.7). Associations between MSD and sanitation were site-specific. Goats were associated with slightly increased odds of MSD in pan-site analyses, whereas associations with cows and fowl varied by site. Poorer types and availability of drinking water sources were consistently associated with MSD, whereas the impacts of sanitation and household animals were context-specific. The association between MSD and access to safely managed drinking water sources post-rotavirus introduction calls for transformational changes in drinking water services to prevent acute child morbidity from MSD.

Sections du résumé

BACKGROUND
Pediatric exposures to unsafe sources of water, unsafely managed sanitation, and animals are prevalent in low- and middle-income countries. In the Vaccine Impact on Diarrhea in Africa case-control study, we examined associations between these risk factors and moderate-to-severe diarrhea (MSD) in children <5 years old in The Gambia, Kenya, and Mali.
METHODS
We enrolled children <5 years old seeking care for MSD at health centers; age-, sex-, and community-matched controls were enrolled at home. Conditional logistic regression models, adjusted for a priori confounders, were used to evaluate associations between MSD and survey-based assessments of water, sanitation, and animals living in the compound.
RESULTS
From 2015 to 2018, 4840 cases and 6213 controls were enrolled. In pan-site analyses, children with drinking water sources below "safely managed" (onsite, continuously accessible sources of good water quality) had 1.5-2.0-fold higher odds of MSD (95% confidence intervals [CIs] ranging from 1.0 to 2.5), driven by rural site results (The Gambia and Kenya). In the urban site (Mali), children whose drinking water source was less available (several hours/day vs all the time) had higher odds of MSD (matched odds ratio [mOR]: 1.4, 95% CI: 1.1, 1.7). Associations between MSD and sanitation were site-specific. Goats were associated with slightly increased odds of MSD in pan-site analyses, whereas associations with cows and fowl varied by site.
CONCLUSIONS
Poorer types and availability of drinking water sources were consistently associated with MSD, whereas the impacts of sanitation and household animals were context-specific. The association between MSD and access to safely managed drinking water sources post-rotavirus introduction calls for transformational changes in drinking water services to prevent acute child morbidity from MSD.

Identifiants

pubmed: 37074438
pii: 7130319
doi: 10.1093/cid/ciac911
pmc: PMC10116493
doi:

Substances chimiques

Drinking Water 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

S132-S139

Informations de copyright

Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.

Déclaration de conflit d'intérêts

Potential conflicts of interest. H. P., R, O., S. O. S., and M. J. H. report receiving grant funding for their institution from the Bill and Melinda Gates Foundation. K. L. K. reports consultation fees and travel support from PATH and the University of Washington related to diarrheal diseases and grant support to her institution from the National Institutes of Health, Institut Pasteur, and the Bill & Melinda Gates Foundation. M. A. W. reports receiving salary pay from the Centers for Disease Control and Prevention and the Institute for Tropical Medicine. S. M. T. reports receiving grant funding for their institution from the Bill and Melinda Gates Foundation, National Institutes of Health, Wellcome Trust, Affinivax, Lumen Biosciences, PATH, and the Medical Research Council. They report receiving royalty payments related to intellectual property for the development of salmonella vaccines and klebsiella/Pseudomonas vaccines and consulting fees and travel support from the University of Washington, in addition to multiple planned, issued and pending patents. They hold an unpaid position on multiple committees with the American Society of Tropical Medicine and Hygiene. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Références

Lancet Infect Dis. 2018 Nov;18(11):1211-1228
pubmed: 30243583
Lancet Glob Health. 2018 Mar;6(3):e316-e329
pubmed: 29396219
Am J Trop Med Hyg. 2013 Oct;89(4):709-16
pubmed: 24002485
PLoS One. 2015 Sep 11;10(9):e0136686
pubmed: 26361393
Water Res. 2013 Sep 15;47(14):5176-88
pubmed: 23866140
Am J Trop Med Hyg. 2016 Nov 2;95(5):1201-1210
pubmed: 27601516
Environ Sci Technol. 2017 Aug 1;51(15):8725-8734
pubmed: 28686435
Vaccine. 2015 Jun 19;33 Suppl 3:C55-61
pubmed: 25902360
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
J Water Health. 2016 Apr;14(2):255-66
pubmed: 27105411
Clin Infect Dis. 2023 Apr 19;76(Supplement_1):S140-S152
pubmed: 37074442
Clin Infect Dis. 2012 Dec;55 Suppl 4:S215-24
pubmed: 23169934
J Appl Microbiol. 2014 Feb;116(2):447-63
pubmed: 24127653
Nutr Res Rev. 2017 Jun;30(1):50-72
pubmed: 28112064
Am J Trop Med Hyg. 2017 Oct;97(4):1009-1019
pubmed: 29031283
PLoS Med. 2007 Nov 27;4(11):e336
pubmed: 18044983
Int J Environ Res Public Health. 2014 Aug 11;11(8):8137-65
pubmed: 25116635
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Environ Sci Technol. 2017 Oct 17;51(20):11537-11552
pubmed: 28926696
PLoS Med. 2015 Oct 27;12(10):e1001892
pubmed: 26505897
Am J Trop Med Hyg. 2017 Oct;97(4):1020-1032
pubmed: 28722599
Clin Infect Dis. 2023 Apr 19;76(Supplement_1):S41-S48
pubmed: 37074430
Environ Sci Technol. 2013 Feb 19;47(4):1994-2000
pubmed: 23323809
Am J Trop Med Hyg. 2017 Jun;96(6):1404-1414
pubmed: 28719269
Am J Trop Med Hyg. 2016 May 4;94(5):1143-9
pubmed: 26928833
Lancet Glob Health. 2019 Aug;7(8):e1139-e1146
pubmed: 31303300
Am J Trop Med Hyg. 2013 Aug;89(2):214-222
pubmed: 23836570
PLoS Negl Trop Dis. 2017 Aug 4;11(8):e0005795
pubmed: 28783751
Clin Infect Dis. 2012 Dec;55 Suppl 4:S232-45
pubmed: 23169936
Lancet. 2017 Jul 15;390(10091):231-266
pubmed: 28528753
Clin Infect Dis. 2023 Apr 19;76(Supplement_1):S5-S11
pubmed: 37074428
PLoS One. 2015 Nov 10;10(11):e0142346
pubmed: 26556044
BMC Public Health. 2019 Jul 10;19(1):926
pubmed: 31291914
Lancet Planet Health. 2019 Aug;3(8):e336-e337
pubmed: 31439312
Environ Sci Technol. 2017 Jul 5;51(13):7542-7551
pubmed: 28582618
Environ Sci Technol. 2012 Feb 21;46(4):2391-7
pubmed: 22242546
PLoS Med. 2016 May 03;13(5):e1002010
pubmed: 27138888
PLoS One. 2018 Jul 3;13(7):e0199304
pubmed: 29969466
J Water Health. 2010 Sep;8(3):417-30
pubmed: 20375471
Lancet Glob Health. 2019 Jul;7(7):e893-e903
pubmed: 31200889

Auteurs

David M Berendes (DM)

Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Kirsten Fagerli (K)

Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Sunkyung Kim (S)

Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Dilruba Nasrin (D)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Helen Powell (H)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Irene N Kasumba (IN)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Sharon M Tennant (SM)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Anna Roose (A)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

M Jahangir Hossain (M)

Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia.

Joquina Chiquita M Jones (JCM)

Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia.

Syed M A Zaman (SMA)

Medical Research Council Unit, The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia.

Richard Omore (R)

Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.

John B Ochieng (JB)

Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.

Jennifer R Verani (JR)

Division of Global Health Protection, Centers for Disease Control and Prevention, Nairobi, Kenya.

Marc-Alain Widdowson (MA)

Division of Global Health Protection, Centers for Disease Control and Prevention, Nairobi, Kenya.

Samba O Sow (SO)

Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.

Sanogo Doh (S)

Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.

Ciara E Sugerman (CE)

Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Eric D Mintz (ED)

Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Karen L Kotloff (KL)

Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH